Reproductive epidemiology

Aiming to improve reproductive health outcomes by providing the best available evidence on treatment effectiveness, diagnostic test accuracy, and prognostic factors.

Dr Rui Wang is a reproductive epidemiologist and NHMRC Emerging Leadership Fellow in the Department of Obstetrics and Gynaecology, Monash University and works closely with the MCHRI team.

We use the start-of-the-art research methodology in epidemiology to answer important clinical research questions on conditions relevant to reproductive health that are prioritised by their end users.

Reproductive epidemiology involves research on treatments, diagnosis and prognosis of reproduction-related conditions. These include infertility, tubal disorders, polycystic ovary syndrome as well pregnancy complications during the course of pregnancy.

The Reproductive Epidemiology Group conduct large collaborative evidence synthesis projects, randomised controlled trials and observational studies to answer questions prioritised by clinicians, consumers and policy makers.

They collaborate with clinicians, methodologists and consumers to produce evidence-based
knowledge base to inform clinical decision-making and improve reproductive outcomes.

We are producing knowledge base on the effectiveness and safety of clinical interventions, accuracy of diagnostic tests and prognostic value of predictors in reproductive medicine to improve health outcomes. Our knowledge base has been implemented in national and international guidelines and consensus. These are used globally to inform patients and clinicians in clinical decision-making.